Search > Manufacturers (11)
- CSL Behring – A Dialogue on Elevating Patient Care for Hemophilia B Patients (3)
- CSL Behring – IDELVION On-Demand by Dr. Escobar (2)
- CSL Behring – IDELVION On-Demand by Dr. Escobar (0)
- CSL Behring – Proven Bleed Protection With Long-Lasting Factor IX Dosing by Dr. Reding (0)
- CSL Behring – Proven Bleed Protection With Long-Lasting Factor IX Dosing by Dr. Reding (0)
- CSL: Coding and Reimbursement Guide – Diagnosis, NDC, and ICD-10-CM Billing Codes for Coagulation Factor IX(Recombinant), Albumin Fusion Protein (0)
- CSL: Field Reimbursement Managers (2)
- HEMA Biologics – SEVENFACT® [coagulation factor VIIa (recombinant)-jncw] by Dr. Pipe (9)
- HEMA Biologics – SEVENFACT® [coagulation factor VIIa (recombinant)-jncw] by Dr. Pipe (0)
- Novo Nordisk - Alhemo Prefilled Pen Overview (pdf) (0)
- Novo Nordisk - Alhemo Prescribing Information, December 2024 (pdf) (0)
- Novo Nordisk - Concizumab Prophylaxis in Patients with Hemophilia A or B with Inhibitors - explorer7 (pdf) (0)
- Novo Nordisk - explorer7-Matsushita T et al. N Engl J Med. 2023;389783-794 (pdf) (1)
- Novo Nordisk - Mathias M et al. Poster PO140 (explorer7- 56 week) presented at 16th European Association for Haemophilia and Allied Disorders, Feb 7-10, 2023; Manchester, UK (pdf) (1)
- Novo Nordisk - Response 00088908 - FLMT-076029 (pdf) (0)
- Novo Nordisk - Tran H et al (explorer7- PROs). Res Pract Thromb Haemost, Published online ahead of print, 2024 (pdf) (0)
- Octapharma - Letter of Support - Stop Proposed Cuts 04-25-2017 (1)
- Octapharma Webinar 02-03-2022 – The 8-CHECK Gene Mutation Testing Service and Implications for Treatment Decision-Making (video/mp4 presentation) (1)
- Octapharma Webinar 06-26-2018 - Treatment of Von Willebrand Disease (video/mp4 presentation) (1)
- Octapharma Webinar 07-22-2025 - Review The Clinical Benefits of wilate (video/mp4 presentation) (0)